Hekmatshoar, Y. Et Al. 2024. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.43, no.7 , 664-684.

Hekmatshoar, Y., Rahbar Saadat, Y., ÖZKAN, T., Bozkurt, S., & KARADAĞ GÜREL, A., (2024). Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.43, no.7, 664-684.

Hekmatshoar, Yalda Et Al. "Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study," NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.43, no.7, 664-684, 2024

Hekmatshoar, Yalda Et Al. "Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study." NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.43, no.7, pp.664-684, 2024

Hekmatshoar, Y. Et Al. (2024) . "Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study." NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS , vol.43, no.7, pp.664-684.

@article{article, author={Yalda Hekmatshoar Et Al. }, title={Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study}, journal={NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS}, year=2024, pages={664-684} }